Acadia Healthcare has agreed to settle $179M with $ACHC investors to resolve claims that it misled them about the performance and compliance of its U.K. operations.
Outline:
Between 2014 and 2018, Acadia Healthcare stated that its U.K. operations were expanding and operating in compliance with regulatory standards. In subsequent disclosures, the company reported issues at certain U.K. facilities, including staffing shortages, patient safety concerns, and unfavorable inspection ratings from U.K. health regulators. Following these disclosures, Acadia’s stock declined by more than 19%, and investors filed a lawsuit.
2014: Acadia Healthcare acquired the Priory Group and entered the U.K. market.
2014–2018: Acadia reported growth and compliance in its U.K. operations.
2016–2018: U.K. regulators identified issues at certain Priory facilities.
November 2018: Acadia disclosed impairments and changes to its U.K. business. $ACHC fell over 19%.
April 2019: Investors filed a class action lawsuit against Acadia.
January 15, 2026: The court gave final approval to the $179 million settlement between Acadia Healthcare and its investors.
Background:
Acadia Healthcare expanded its operations into the United Kingdom as part of its international growth strategy. A key element of this expansion was the acquisition of the Priory Group, which added a large number of behavioral health facilities in the U.K. to Acadia’s portfolio.
From 2014 through late 2018, Acadia stated that its U.K. operations were being integrated into the company’s business and were performing in line with expectations. The company reported that these operations were profitable and operating in compliance with applicable regulatory standards.
During this period, inspections conducted by the U.K. Care Quality Commission (CQC) identified operational issues at a number of Priory facilities. CQC reports cited concerns related to staffing levels, patient safety, and quality of care at certain locations.
The CQC issued citations and enforcement actions against multiple facilities operated by Priory for violations of safety and staffing requirements.
In November 2018, Acadia announced changes to its U.K. operations, including a restructuring of the business and asset impairments related to its international segment.
Following this announcement, $ACHC declined by approximately 19% in one trading day.
After these disclosures, investors filed a lawsuit, claiming that Acadia failed to disclose internal operational and regulatory issues.
What Can Investors Expect Now?
Acadia Healthcare has agreed to settle $179M with $ACHC investors to resolve claims that it misled them about the performance and compliance of its U.K. operations.